Yongming Ma
Papers
1
Total Citations
11
H-Index
1
About
Yongming Ma is a pioneering researcher at the intersection of artificial intelligence, robotics, and aging biology. His work centers on developing automated, AI-driven platforms to accelerate the discovery of therapeutic interventions for age-related diseases. Ma’s most notable contribution is the creation of a fully autonomous robotics laboratory that identified TNIK inhibition as a potent senomorphic agent—a compound that suppresses the harmful effects of cellular senescence without killing senescent cells. This breakthrough, published in 2024 and already garnering 11 citations, demonstrates how AI can prioritize dual-purpose longevity targets while simultaneously developing drugs that combat both aging and disease. By integrating machine learning with high-throughput robotic experimentation, Ma has established a paradigm for systematically assessing interventions against the hallmarks of aging. His approach represents a significant leap from traditional drug discovery, offering a scalable, unbiased method to uncover therapies that address aging as a root cause of chronic disease. For students and researchers, Ma’s work exemplifies how computational and physical automation can converge to solve one of biomedicine’s grand challenges: extending healthspan through precision geroscience.
Research Focus
Key Achievements
Top Papers
- 1